Fred Alger Management, LLC Regenxbio Inc. Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $859,680 - $1.37 Million	-27,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $210,000 - $296,450	-5,000 Reduced 15.63%	27,000 $1.39 Million
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $1.31 Million - $2 Million	32,000 New	32,000 $1.83 Million
Q3 2018 Nov 14, 2018	SELL	$65.0 - $82.15 $845,000 - $1.07 Million	-13,000 Closed	0 $0
Q2 2018 Jul 19, 2018	BUY	$27.2 - $74.35 $353,600 - $966,549	13,000 New	13,000 $933,000

197

43.2M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $416M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.